Extended Data Fig. 4: Representation of the data and analytical workflow defined to investigate the predictive value of genetics in all target/disease associations derived from clinical trials.
From: Genetic factors associated with reasons for clinical trial stoppage
Except for the baseline expression data, all datasets were sourced from the Open Targets 22.04 release. Detailed methods can be found in the Methods section.
